Specialties
Reports that name this provider
- Stem Cell Therapy Quality in Brazil
- FACT-accredited for adult and pediatric allogeneic/autologous HCT and immune effector cellular therapy
- Stem Cell Transplant Quality in Brazil
- FACT-JACIE accredited; achieved 78% overall survival for ALL and 88% for AML with post-transplant maintenance therapy (applied from 2021 onward)